by rdbiomed | Apr 6, 2021 | Company Updates
Professor Peter Dettmar and Professor Jeffery Pearson, world renowned experts in pepsin, will present key papers on gastroesophageal reflux disease in an international journal. Annals of Esophagus publishes leading-edge findings, techniques and opinions in all fields... 
by rdbiomed | Mar 8, 2021 | Reflux Tips & News
Children that take proton pump inhibitors medication (PPIs) are more likely to have asthma than those that don’t, a study published in JAMA Pediatrics has revealed. PPIs, which include esomeprazole (Nexium), lansoprazole (Zoton), omeprazole (Losec), pantoprazole... 
by rdbiomed | Mar 8, 2021 | Company Updates
Professor Peter Dettmar has shared insight into how prevalent gastroesophageal reflux disease (GERD) is across the world in an article published in the international journal Annals of Esophagus. His narrative review, written in collaboration with Katie Boulton, looks... 
by rdbiomed | Mar 5, 2021 | Company Updates, Latest Pepsin Research
We’re excited to hear that Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary. Many people associate reflux with symptoms, such as heartburn or acid reflux, but it can also cause... 
by rdbiomed | Mar 2, 2021 | Reflux Tips & News
Do you suffer from reflux-related symptoms? Northumbria University is looking for recruits to take part in a study investigating foods that trigger reflux and upper GI symptoms. Undergraduate students at the University are running a questionnaire-based study into...
Recent Comments